Company / Inventory
Biogen Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$2.2B
FY2025
5-year range
$1.3B / $2.5B
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#12 of 108
Health Care
What the data says
Biogen's inventory of $2.2B is higher than 89% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $804M in FY2019 to $2.5B in FY2023.
Based on SEC 10-K filings.
$2.2B in FY2025 with a 5-year CAGR of +15.2%. Top quartile in the Health Care sector.
Declined from $2.5B to $2.2B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +17.3%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 108This company $2.2B Sector average $862.4M
▼
+151.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.2%, indicating consistent growth.
- In FY2025, inventory decreased 11.9% year-over-year.
- Ranks #12 out of 108 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | -11.9% |
| FY2024 | $2.5B | -2.6% |
| FY2023 | $2.5B | +88.0% |
| FY2022 | $1.3B | -0.5% |
| FY2021 | $1.4B | +26.5% |
| FY2020 | $1.1B | +32.9% |
| FY2019 | $804.2M | -13.5% |
| FY2018 | $929.9M | +3.0% |
| FY2017 | $902.7M | -9.9% |
| FY2016 | $1.0B | +12.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026